Oxcarbazepine Tablet, Film Coated
Product Images NDC 60429-062

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 60429-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60429 061 05lb

OXCARBAZEPINE is a medication available in tablet form, with a strength of 150mg. The package contains 500 tablets. Dosage information is provided in the package insert. A medication guide from Pharmagrt is also provided to the patient and can be printed at https://igsms.us/. The tablets should be stored at a temperature between 20°C and 25°C (68°F-77°F), with excursions permitted between 15°C and 30°C (59°F-86°F). The rest of the text appears to be gibberish.*

FDA Label Image

60429 062 05lb

This is a description for a medication called OXCARBAZEPINE, which is available in the form of tablets. The package contains 500 tablets with a strength of 300 mg. The text also includes a reference to a medication guide that needs to be printed for each patient. No further useful information could be obtained from the text.*

FDA Label Image

60429 063 05lb

This is a pharmaceutical label for Oxcarbazepine Tablets. The NDC code, dosage strength, and quantity are provided. The medication should be stored in a tight container and kept away from children. Manufacturing and packaging information is also provided.*

FDA Label Image

Oxcarbazepine 01

FDA Label Image

Oxcarbazepine 02

The text provides the results of a Tog-rank test with a p-value of 0.0001. Additionally, there is a chart with two rows displaying 'T' characters and numbers 0-9, and two columns labeled 'Day2' and 'Day11' with times of 8am for each. The chart also shows two treatment groups: Oxcarbazepine and Placebo. No further information is available.*

FDA Label Image

Oxcarbazepine 03

The text describes the seizure rate for two treatment groups, Oxcarbazepine and Placebo, over a period of time. The log-rank test resulted in a p-value of 0.046, suggesting a significant difference between the two groups. The x-axis represents the number of days from the first dose to the first seizure, while the y-axis shows the number of seizures.*

FDA Label Image

Oxcarbazepine 04

FDA Label Image

Oxcarbazepine 05

This appears to be a survival plot depicting the cumulative survival of two groups (HIGH and LOW) over a specified period. The graph shows the percentage of surviving participants at different time points ranging from 0 to 130 days. The log-rank test was employed to compare the survival curves of both groups and the p-value was found to be 0.0001.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.